| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| candoxatril | angiotensin-converting enzyme | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
1.93 | experimental | inhibitor |
| candoxatril | neutral endopeptidase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
24.48 | phase 3 | unknown |
| candoxatril | neprilysin | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
24.48 | experimental | inhibitor |
| candoxatril | neutral endopeptidase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
24.48 | phase 3 | inhibitor |
| click here to return to the previous page | ||||||||